Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of Pulmonary Dysfunction in Systemic Juvenile Idiopathic Arthritis Using Xenon and Proton MRI.

Pediatric pulmonology·2026

Same author

Recommendations From the Blue Ribbon Panel on Fluoroscopy Safety.

Journal of the American College of Radiology : JACR·2026

Same author

Medication-induced lung disease in children.

Pediatric radiology·2025

Same author

Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement study.

European radiology·2025

Same author

Neonatal and Pediatric Pulmonary Vascular Disease.

Radiologic clinics of North America·2025

Same author

The incidental pediatric pulmonary nodule: What to ignore, what to worry about.

Pediatric pulmonology·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Contemporary perspectives on pediatric diffuse lung disease.

R Paul Guillerman¹, Alan S Brody

¹Department of Pediatric Radiology, Texas Children's Hospital, Baylor College of Medicine, 6701 Fannin Street, Houston, TX 77030, USA. rpguille@texaschildrens.org

Radiologic Clinics of North America

|September 6, 2011

Summary

This summary is machine-generated.

Obtaining optimal computed tomography images of pediatric lungs is difficult due to motion artifact and unique childhood lung diseases. A new classification aids in diagnosing and treating diffuse lung disease in children.

Related Experiment Videos

Last Updated: May 29, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Area of Science:

Pediatric Radiology
Pulmonology
Medical Imaging

Background:

Computed tomography (CT) imaging of the pediatric lung parenchyma presents challenges, particularly achieving optimal lung volumes without motion artifact.
Diffuse lung diseases manifest differently in children compared to adults, with some conditions being unique to pediatric populations.

Purpose of the Study:

To address the challenges in pediatric lung imaging and the distinct nature of diffuse lung diseases in children.
To introduce a novel classification scheme for pediatric diffuse lung disease.

Main Methods:

Review and synthesis of existing literature on pediatric diffuse lung diseases and imaging techniques.
Development of a new classification system based on recognized differences between pediatric and adult lung diseases.
Correlation of imaging findings with specific pediatric diffuse lung disorders.

Main Results:

Identification of specific challenges in obtaining high-quality pediatric lung CT scans.
Highlighting the unique epidemiological and pathological features of diffuse lung diseases in children.
Establishment of a new classification scheme tailored for pediatric diffuse lung disease.

Conclusions:

Accurate diagnosis and effective treatment of pediatric diffuse lung disease rely on understanding these age-specific differences.
The proposed classification scheme and recognition of characteristic imaging findings are crucial for clinical management.
Improved diagnostic accuracy and treatment strategies for children with diffuse lung conditions are anticipated.